View ValuationRianlon 향후 성장Future 기준 점검 1/6Rianlon (는) 각각 연간 18.2% 및 13% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 18.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 12% 로 예상됩니다.핵심 정보18.2%이익 성장률18.26%EPS 성장률Chemicals 이익 성장29.6%매출 성장률13.0%향후 자기자본이익률11.98%애널리스트 커버리지Low마지막 업데이트06 May 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 28Rianlon Corporation, Annual General Meeting, May 25, 2026Rianlon Corporation, Annual General Meeting, May 25, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China공시 • Mar 31Rianlon Corporation to Report Q1, 2026 Results on Apr 28, 2026Rianlon Corporation announced that they will report Q1, 2026 results on Apr 28, 2026공시 • Dec 31Rianlon Corporation to Report Fiscal Year 2025 Results on Apr 28, 2026Rianlon Corporation announced that they will report fiscal year 2025 results on Apr 28, 2026공시 • Sep 30Rianlon Corporation to Report Q3, 2025 Results on Oct 21, 2025Rianlon Corporation announced that they will report Q3, 2025 results on Oct 21, 2025공시 • Jul 02Rianlon Corporation to Report First Half, 2025 Results on Aug 28, 2025Rianlon Corporation announced that they will report first half, 2025 results on Aug 28, 2025공시 • May 22Rianlon Corporation Approves Dividend for 2024Rianlon Corporation its Annual General Meeting of 2024 on 16 May 2025, during which the following proposal(s) was/were approved: Cash dividend per 10 shares (tax included): CNY 3.70000000.공시 • Apr 23Rianlon Corporation Proposes Final Cash Dividend for 2024Rianlon Corporation proposed final cash dividend of CNY 3.70000000 per 10 shares (tax included) for 2024.공시 • Apr 22Rianlon Corporation, Annual General Meeting, May 16, 2025Rianlon Corporation, Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China공시 • Mar 31Rianlon Corporation to Report Q1, 2025 Results on Apr 29, 2025Rianlon Corporation announced that they will report Q1, 2025 results on Apr 29, 2025공시 • Dec 31Rianlon Corporation to Report Fiscal Year 2024 Results on Apr 22, 2025Rianlon Corporation announced that they will report fiscal year 2024 results on Apr 22, 2025Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.44 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.41 (down from CN¥0.44 in 3Q 2023). Revenue: CN¥1.45b (up 6.9% from 3Q 2023). Net income: CN¥93.8m (down 6.5% from 3Q 2023). Profit margin: 6.5% (down from 7.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 9% per year.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥28.12, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years.공시 • Sep 30Rianlon Corporation to Report Q3, 2024 Results on Oct 29, 2024Rianlon Corporation announced that they will report Q3, 2024 results on Oct 29, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥26.77, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.49 (vs CN¥0.43 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.43 in 2Q 2023). Revenue: CN¥1.47b (up 11% from 2Q 2023). Net income: CN¥113.0m (up 13% from 2Q 2023). Profit margin: 7.7% (up from 7.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.공시 • Jun 29Rianlon Corporation to Report First Half, 2024 Results on Aug 26, 2024Rianlon Corporation announced that they will report first half, 2024 results on Aug 26, 2024Declared Dividend • Jun 27Dividend of CN¥0.34 announcedDividend of CN¥0.34 is the same as last year. Ex-date: 2nd July 2024 Payment date: 2nd July 2024 Dividend yield will be 1.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 86% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Jun 26Rianlon Corporation Announces Final Dividend of A Shares for 2023, Payable on July 2, 2024Rianlon Corporation announced final cash dividend of CNY 3.44000000 per 10 A shares for 2023. Record date: 01 July 2024. Ex-date: 02 July 2024. Payment date: 02 July 2024.New Risk • Apr 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (11% average weekly change).Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥27.51, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years.공시 • Apr 19Rianlon Corporation, Annual General Meeting, May 13, 2024Rianlon Corporation, Annual General Meeting, May 13, 2024, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin ChinaReported Earnings • Apr 18Full year 2023 earnings released: EPS: CN¥1.58 (vs CN¥2.40 in FY 2022)Full year 2023 results: EPS: CN¥1.58 (down from CN¥2.40 in FY 2022). Revenue: CN¥5.28b (up 9.0% from FY 2022). Net income: CN¥362.5m (down 31% from FY 2022). Profit margin: 6.9% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공시 • Mar 30Rianlon Corporation to Report Q1, 2024 Results on Apr 27, 2024Rianlon Corporation announced that they will report Q1, 2024 results on Apr 27, 2024New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (7.3% net profit margin).Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥20.32, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.공시 • Dec 29Rianlon Corporation to Report Fiscal Year 2023 Results on Apr 18, 2024Rianlon Corporation announced that they will report fiscal year 2023 results on Apr 18, 2024Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.70 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.44 (down from CN¥0.70 in 3Q 2022). Revenue: CN¥1.35b (up 1.9% from 3Q 2022). Net income: CN¥100.3m (down 38% from 3Q 2022). Profit margin: 7.4% (down from 12% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.공시 • Sep 30Rianlon Corporation to Report Q3, 2023 Results on Oct 24, 2023Rianlon Corporation announced that they will report Q3, 2023 results on Oct 24, 2023Board Change • Sep 28Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Non-Independent Director Borui Han was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.70 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.43 (down from CN¥0.70 in 2Q 2022). Revenue: CN¥1.32b (up 5.0% from 2Q 2022). Net income: CN¥99.7m (down 33% from 2Q 2022). Profit margin: 7.6% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.공시 • Jul 01Rianlon Corporation to Report First Half, 2023 Results on Aug 25, 2023Rianlon Corporation announced that they will report first half, 2023 results on Aug 25, 2023공시 • Jun 15Rianlon Corporation Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 21, 2023Rianlon Corporation announced final cash dividend of CNY 3.44 per 10 shares on A shares for the year 2022. Record date is June 20, 2023, Ex-Date is June 21, 2023 and Payment Date is June 21, 2023.Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥2.40 (vs CN¥2.04 in FY 2021)Full year 2022 results: EPS: CN¥2.40 (up from CN¥2.04 in FY 2021). Revenue: CN¥4.84b (up 41% from FY 2021). Net income: CN¥525.7m (up 26% from FY 2021). Profit margin: 11% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.55 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.55 in 3Q 2021). Revenue: CN¥1.33b (up 46% from 3Q 2021). Net income: CN¥160.7m (up 42% from 3Q 2021). Profit margin: 12% (in line with 3Q 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.47 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.47 in 2Q 2021). Revenue: CN¥1.26b (up 58% from 2Q 2021). Net income: CN¥148.1m (up 54% from 2Q 2021). Profit margin: 12% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 26%, compared to a 42% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • May 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥45.88, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 15% over the past year.Reported Earnings • Apr 28First quarter 2022 earnings released: EPS: CN¥0.62 (vs CN¥0.44 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.62 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥1.01b (up 23% from 1Q 2021). Net income: CN¥126.2m (up 40% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Wei Man Hou was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 02Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.43 in FY 2020). Revenue: CN¥3.44b (up 39% from FY 2020). Net income: CN¥417.6m (up 43% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue exceeded analyst estimates by 7.8%. Over the next year, revenue is forecast to grow 19%, compared to a 47% growth forecast for the industry in China.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.55 (vs CN¥0.38 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥908.7m (up 52% from 3Q 2020). Net income: CN¥113.4m (up 45% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥36.01, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 14% over the past year.Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.35 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥795.3m (up 38% from 2Q 2020). Net income: CN¥95.9m (up 34% from 2Q 2020). Profit margin: 12% (in line with 2Q 2020).Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.31 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥821.4m (up 46% from 1Q 2020). Net income: CN¥90.4m (up 43% from 1Q 2020). Profit margin: 11% (in line with 1Q 2020).Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.21, the stock trades at a trailing P/E ratio of 28.1x, up from the previous P/E ratio of 23.9x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 41%.Reported Earnings • Mar 09Full year 2020 earnings released: EPS CN¥1.43 (vs CN¥1.38 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥2.48b (up 26% from FY 2019). Net income: CN¥293.0m (up 12% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Mar 09Revenue beats expectationsRevenue exceeded analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China.Is New 90 Day High Low • Jan 31New 90-day low: CN¥34.20The company is down 6.0% from its price of CN¥36.39 on 03 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥6.01 per share.Is New 90 Day High Low • Dec 04New 90-day high: CN¥44.00The company is up 25% from its price of CN¥35.07 on 04 September 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.63 per share.Is New 90 Day High Low • Nov 14New 90-day high: CN¥39.29The company is up 7.0% from its price of CN¥36.84 on 14 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.82 per share.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥256.7m, down 2.7% from the prior year. Total revenue was CN¥2.28b over the last 12 months, up 27% from the prior year.이익 및 매출 성장 예측XSEC:300596 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20288,925877N/A1,435312/31/20278,004748N/A1,296512/31/20266,978633N/A1,329412/31/20256,023497136378N/A9/30/20255,931505206458N/A6/30/20255,86244798286N/A3/31/20255,814427116350N/A12/31/20245,687426209464N/A9/30/20245,686393-22348N/A6/30/20245,593400-239249N/A3/31/20245,447387-293256N/A12/31/20235,278362-401173N/A9/30/20235,106374-203292N/A6/30/20235,08143446426N/A3/31/20235,01848287369N/A1/1/20234,843526221514N/A9/30/20224,514553190498N/A6/30/20224,096506-57414N/A3/31/20223,634453-201304N/A12/31/20213,445418-203312N/A9/30/20213,270379-201271N/A6/30/20212,960344-232141N/A3/31/20212,741320-160220N/A12/31/20202,483293-146187N/A9/30/20202,282257-146248N/A6/30/20202,253272-79308N/A3/31/20202,132272-170197N/A12/31/20191,978262-230166N/A9/30/20191,792264N/A-51N/A6/30/20191,640232N/A-43N/A3/31/20191,574211N/A57N/A12/31/20181,488193N/A35N/A9/30/20181,401185N/A75N/A6/30/20181,295159N/A58N/A3/31/20181,181136N/A-19N/A12/31/20171,142131N/A31N/A9/30/20171,089111N/A43N/A6/30/201798999N/A0N/A3/31/201789996N/A29N/A12/31/201680891N/A24N/A9/30/201671990N/A15N/A12/31/201560574N/A81N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 300596 의 연간 예상 수익 증가율(18.2%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 300596 의 연간 수익(18.2%)이 CN 시장(26.8%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 300596 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 300596 의 수익(연간 13%)이 CN 시장(연간 15.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 300596 의 수익(연간 13%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 300596의 자본 수익률은 3년 후 12%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/15 05:18종가2026/05/15 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Rianlon Corporation는 13명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Wang PengChina Galaxy Securities Co., Ltd.Wenpo RenChina Galaxy Securities Co., Ltd.Qidi ZhaiChina Galaxy Securities Co., Ltd.10명의 분석가 더 보기
공시 • Apr 28Rianlon Corporation, Annual General Meeting, May 25, 2026Rianlon Corporation, Annual General Meeting, May 25, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China
공시 • Mar 31Rianlon Corporation to Report Q1, 2026 Results on Apr 28, 2026Rianlon Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
공시 • Dec 31Rianlon Corporation to Report Fiscal Year 2025 Results on Apr 28, 2026Rianlon Corporation announced that they will report fiscal year 2025 results on Apr 28, 2026
공시 • Sep 30Rianlon Corporation to Report Q3, 2025 Results on Oct 21, 2025Rianlon Corporation announced that they will report Q3, 2025 results on Oct 21, 2025
공시 • Jul 02Rianlon Corporation to Report First Half, 2025 Results on Aug 28, 2025Rianlon Corporation announced that they will report first half, 2025 results on Aug 28, 2025
공시 • May 22Rianlon Corporation Approves Dividend for 2024Rianlon Corporation its Annual General Meeting of 2024 on 16 May 2025, during which the following proposal(s) was/were approved: Cash dividend per 10 shares (tax included): CNY 3.70000000.
공시 • Apr 23Rianlon Corporation Proposes Final Cash Dividend for 2024Rianlon Corporation proposed final cash dividend of CNY 3.70000000 per 10 shares (tax included) for 2024.
공시 • Apr 22Rianlon Corporation, Annual General Meeting, May 16, 2025Rianlon Corporation, Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China
공시 • Mar 31Rianlon Corporation to Report Q1, 2025 Results on Apr 29, 2025Rianlon Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
공시 • Dec 31Rianlon Corporation to Report Fiscal Year 2024 Results on Apr 22, 2025Rianlon Corporation announced that they will report fiscal year 2024 results on Apr 22, 2025
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.44 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.41 (down from CN¥0.44 in 3Q 2023). Revenue: CN¥1.45b (up 6.9% from 3Q 2023). Net income: CN¥93.8m (down 6.5% from 3Q 2023). Profit margin: 6.5% (down from 7.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 9% per year.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥28.12, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years.
공시 • Sep 30Rianlon Corporation to Report Q3, 2024 Results on Oct 29, 2024Rianlon Corporation announced that they will report Q3, 2024 results on Oct 29, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥26.77, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.49 (vs CN¥0.43 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.43 in 2Q 2023). Revenue: CN¥1.47b (up 11% from 2Q 2023). Net income: CN¥113.0m (up 13% from 2Q 2023). Profit margin: 7.7% (up from 7.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings.
공시 • Jun 29Rianlon Corporation to Report First Half, 2024 Results on Aug 26, 2024Rianlon Corporation announced that they will report first half, 2024 results on Aug 26, 2024
Declared Dividend • Jun 27Dividend of CN¥0.34 announcedDividend of CN¥0.34 is the same as last year. Ex-date: 2nd July 2024 Payment date: 2nd July 2024 Dividend yield will be 1.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (20% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 26% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 86% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Jun 26Rianlon Corporation Announces Final Dividend of A Shares for 2023, Payable on July 2, 2024Rianlon Corporation announced final cash dividend of CNY 3.44000000 per 10 A shares for 2023. Record date: 01 July 2024. Ex-date: 02 July 2024. Payment date: 02 July 2024.
New Risk • Apr 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (11% average weekly change).
Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥27.51, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years.
공시 • Apr 19Rianlon Corporation, Annual General Meeting, May 13, 2024Rianlon Corporation, Annual General Meeting, May 13, 2024, at 15:00 China Standard Time. Location: The Company's Meeting Room, Tianjin China
Reported Earnings • Apr 18Full year 2023 earnings released: EPS: CN¥1.58 (vs CN¥2.40 in FY 2022)Full year 2023 results: EPS: CN¥1.58 (down from CN¥2.40 in FY 2022). Revenue: CN¥5.28b (up 9.0% from FY 2022). Net income: CN¥362.5m (down 31% from FY 2022). Profit margin: 6.9% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공시 • Mar 30Rianlon Corporation to Report Q1, 2024 Results on Apr 27, 2024Rianlon Corporation announced that they will report Q1, 2024 results on Apr 27, 2024
New Risk • Feb 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (7.3% net profit margin).
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥20.32, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
공시 • Dec 29Rianlon Corporation to Report Fiscal Year 2023 Results on Apr 18, 2024Rianlon Corporation announced that they will report fiscal year 2023 results on Apr 18, 2024
Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.70 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.44 (down from CN¥0.70 in 3Q 2022). Revenue: CN¥1.35b (up 1.9% from 3Q 2022). Net income: CN¥100.3m (down 38% from 3Q 2022). Profit margin: 7.4% (down from 12% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
공시 • Sep 30Rianlon Corporation to Report Q3, 2023 Results on Oct 24, 2023Rianlon Corporation announced that they will report Q3, 2023 results on Oct 24, 2023
Board Change • Sep 28Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Non-Independent Director Borui Han was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.70 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.43 (down from CN¥0.70 in 2Q 2022). Revenue: CN¥1.32b (up 5.0% from 2Q 2022). Net income: CN¥99.7m (down 33% from 2Q 2022). Profit margin: 7.6% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
공시 • Jul 01Rianlon Corporation to Report First Half, 2023 Results on Aug 25, 2023Rianlon Corporation announced that they will report first half, 2023 results on Aug 25, 2023
공시 • Jun 15Rianlon Corporation Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 21, 2023Rianlon Corporation announced final cash dividend of CNY 3.44 per 10 shares on A shares for the year 2022. Record date is June 20, 2023, Ex-Date is June 21, 2023 and Payment Date is June 21, 2023.
Reported Earnings • Apr 08Full year 2022 earnings released: EPS: CN¥2.40 (vs CN¥2.04 in FY 2021)Full year 2022 results: EPS: CN¥2.40 (up from CN¥2.04 in FY 2021). Revenue: CN¥4.84b (up 41% from FY 2021). Net income: CN¥525.7m (up 26% from FY 2021). Profit margin: 11% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.55 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.55 in 3Q 2021). Revenue: CN¥1.33b (up 46% from 3Q 2021). Net income: CN¥160.7m (up 42% from 3Q 2021). Profit margin: 12% (in line with 3Q 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.47 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.70 (up from CN¥0.47 in 2Q 2021). Revenue: CN¥1.26b (up 58% from 2Q 2021). Net income: CN¥148.1m (up 54% from 2Q 2021). Profit margin: 12% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 26%, compared to a 42% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • May 03Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥45.88, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 15% over the past year.
Reported Earnings • Apr 28First quarter 2022 earnings released: EPS: CN¥0.62 (vs CN¥0.44 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.62 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥1.01b (up 23% from 1Q 2021). Net income: CN¥126.2m (up 40% from 1Q 2021). Profit margin: 13% (up from 11% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 1 highly experienced director. 3 independent directors (6 non-independent directors). Independent Director Wei Man Hou was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 02Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥2.04 (up from CN¥1.43 in FY 2020). Revenue: CN¥3.44b (up 39% from FY 2020). Net income: CN¥417.6m (up 43% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue exceeded analyst estimates by 7.8%. Over the next year, revenue is forecast to grow 19%, compared to a 47% growth forecast for the industry in China.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.55 (vs CN¥0.38 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥908.7m (up 52% from 3Q 2020). Net income: CN¥113.4m (up 45% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020).
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥36.01, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 14% over the past year.
Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.35 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥795.3m (up 38% from 2Q 2020). Net income: CN¥95.9m (up 34% from 2Q 2020). Profit margin: 12% (in line with 2Q 2020).
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.31 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: CN¥821.4m (up 46% from 1Q 2020). Net income: CN¥90.4m (up 43% from 1Q 2020). Profit margin: 11% (in line with 1Q 2020).
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥40.21, the stock trades at a trailing P/E ratio of 28.1x, up from the previous P/E ratio of 23.9x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 41%.
Reported Earnings • Mar 09Full year 2020 earnings released: EPS CN¥1.43 (vs CN¥1.38 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥2.48b (up 26% from FY 2019). Net income: CN¥293.0m (up 12% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Mar 09Revenue beats expectationsRevenue exceeded analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 15%, compared to a 51% growth forecast for the Chemicals industry in China.
Is New 90 Day High Low • Jan 31New 90-day low: CN¥34.20The company is down 6.0% from its price of CN¥36.39 on 03 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥6.01 per share.
Is New 90 Day High Low • Dec 04New 90-day high: CN¥44.00The company is up 25% from its price of CN¥35.07 on 04 September 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.63 per share.
Is New 90 Day High Low • Nov 14New 90-day high: CN¥39.29The company is up 7.0% from its price of CN¥36.84 on 14 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.82 per share.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥256.7m, down 2.7% from the prior year. Total revenue was CN¥2.28b over the last 12 months, up 27% from the prior year.